HCA Healthcare

Leading Healthcare Brands Partnering with BPD Recognized with 16 Honors from Four Award Organizations

Retrieved on: 
목요일, 5월 9, 2024
AAF, Media, Health equity, Television advertisement, COVID, Social media, Judge, Hospital, American Advertising Federation, Digital video, Health, Television, National Research Corporation, Health care, Hand, HCA Healthcare, BPD, UC, Animation, Nursing, Content management, Shorty Awards, AdventHealth, Gold, Mosaic, Marketing, Advertising, Social justice, Webby Awards, College, Robert, Creative industries

BOCA RATON, Fla., May 9, 2024 /PRNewswire/ -- In collaboration with BPD, a leading marketing services firm, 10 leading healthcare brands were recently honored with 16 awards for campaigns by four awards organizations.

Key Points: 
  • 10 BPD clients have been recognized by the Webbys, the Shorty Awards, the American Advertising Awards, and the Healthcare Advertising Awards.
  • BOCA RATON, Fla., May 9, 2024 /PRNewswire/ -- In collaboration with BPD, a leading marketing services firm, 10 leading healthcare brands were recently honored with 16 awards for campaigns by four awards organizations.
  • We are looking forward to continuing to produce creative, powerful, data-driven campaigns for our clients in the healthcare industry."
  • Learn more about how BPD can help your organization drive revenue and ignite greatness in your brand here: www.bpdhealthcare.com .

AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion

Retrieved on: 
목요일, 5월 9, 2024
Slate, Amedisys, CFO, ABA, Palliative care, Elevance Health, Speech, HCA Healthcare, Caesars Entertainment, Knowledge, Humana, ELV, Medicare, Health, Sale, Capital, HCA, BKD, LHC, History, Senior, Patient, Acquisition, Hospice, Interim, Annual general meeting, Audit, Nursing

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the below statement expressing its disappointment in the conclusion of Enhabit’s strategic review.

Key Points: 
  • NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the below statement expressing its disappointment in the conclusion of Enhabit’s strategic review.
  • “We are disappointed that Enhabit’s strategic review process has concluded without a sale of the Company.
  • In March, we nominated a slate of seven highly qualified candidates to stand for election at the 2024 Annual Meeting.
  • He also served myNEXUS as a Vice Chairman and in a strategic advisor role from 2018 to 2019.

MATTERWORKS ANNOUNCES UPDATES TO LEADERSHIP TEAM

Retrieved on: 
목요일, 5월 2, 2024
MALDI, Cancer Institute, AI, HCA, Systems biology, HCA Healthcare, Proteomics, Biomedical Research, Creativity, Mass spectrometry, Applied Biosystems, Medical device

SOMERVILLE, Mass., May 2, 2024 /PRNewswire/ -- Matterworks, Inc., whose foundational AI platform and predictive biology applications accelerate life sciences discovery and development, today announces additions to its leadership team.

Key Points: 
  • SOMERVILLE, Mass., May 2, 2024 /PRNewswire/ -- Matterworks, Inc., whose foundational AI platform and predictive biology applications accelerate life sciences discovery and development, today announces additions to its leadership team.
  • She joined Matterworks from Novartis Institutes of Biomedical Research in 2021 to lead R&D from initial product conceptualization through development and early customer testing.
  • "I could not be more thrilled to have Jenn Campbell and Niall O'Connor as part of the Matterworks organization," said Dr. Jack Geremia, Matterworks CEO.
  • Their talents will advance Matterworks into our next phase of technology leadership and commercial deployment."

March of Dimes Launches Low Dose, Big Benefits™ Campaign to Combat Preeclampsia and Preterm Birth

Retrieved on: 
수요일, 5월 1, 2024
Education, Mortality, Element, Preterm birth, Risk, Vaccine, Philips Avent, Diagnosis, Death, FACOG, Knowledge, Pregnancy, Woman, CDC, The Harris Poll, Infant, Black, Stanford University, Faculty, Pharmacist, Media, Partner, Fear, Aspirin, Health, The Honest Company, Research, Pre-eclampsia, Mental health, MPH, Medicine, Biology, Disease, Society, Blood pressure, Quality, HCA Healthcare, IHeartRadio, Initiative, Patient, Hypertension, MBA, Birth control

ARLINGTON, Va., May 1, 2024 /PRNewswire/ -- March of Dimes, the leading organization fighting for the health of all moms and babies, today announced the launch of Low Dose, Big Benefits, a multi-year campaign aimed at decreasing the adverse effects of preeclampsia and preterm birth through the use of low dose aspirin. The new campaign will feature US Olympian and Entrepreneur Allyson Felix as a brand ambassador and is part of the March of Dimes' It Starts With Mom platform, which provides families with educational information and resources during their pregnancy journey. It Starts With Mom is generously supported by trusted partners, including HCA Healthcare, Clearblue, Goldbug, The Honest Company, Philips Avent, and Sanofi.

Key Points: 
  • Preeclampsia is a potentially fatal condition that causes a pregnant woman's blood pressure to rise and can lead to preterm birth, heart disease, and other complications.
  • Studies show that pregnant people at an increased risk for preeclampsia who take low dose aspirin may reduce their risk of preeclampsia by 15% and their risk of preterm birth by 20%.
  • Low Dose, Big Benefits is the culmination of March of Dimes' legacy since 1938 of funding research to help millions of babies survive and thrive.
  • The organization went on to create the Prematurity Campaign Roadmap in 2015 that identified eight interventions that could reduce the preterm birth rate and included low dose aspirin.

Next DLP Announces First Security Solution to Automatically Map to MITRE's Insider Threat Knowledge Base

Retrieved on: 
화요일, 4월 30, 2024
Knowledge, Chase Bank, Lloyds Banking Group, JPMorgan Chase, CrowdStrike, Technique, Head, Insider threat, Risk, Partnership, HCA Healthcare, Digital, MITRE, DLP, Microsoft, Data collection, Next, Verizon Business, Risk management

BOSTON and LONDON, April 30, 2024 /PRNewswire-PRWeb/ -- Next DLP ("Next"), a leader in data loss prevention and insider threat solutions, today announced that their Reveal Platform is the first Insider Risk Management solution to automatically map detection events to MITRE Engenuity Center for Threat-Informed Defense's ("Center") expanded Insider Threat Knowledge Base (ITKB 2.0). The ITKB 2.0 is the first of its kind to offer an evidence-based, multi-organizational and publicly-available compendium of insider threat tactics, techniques, and procedures (TTPs). This endeavor was developed in partnership between MITRE, Next DLP, CrowdStrike, HCA Healthcare, JPMorgan Chase Bank, N.A., Lloyds Banking Group, Microsoft Corporation and Verizon Business.

Key Points: 
  • BOSTON and LONDON, April 30, 2024 /PRNewswire-PRWeb/ -- Next DLP ("Next"), a leader in data loss prevention and insider threat solutions, today announced that their Reveal Platform is the first Insider Risk Management solution to automatically map detection events to MITRE Engenuity Center for Threat-Informed Defense's ("Center") expanded Insider Threat Knowledge Base (ITKB 2.0) .
  • The ITKB 2.0 is the first of its kind to offer an evidence-based, multi-organizational and publicly-available compendium of insider threat tactics, techniques, and procedures (TTPs).
  • "With Reveal, and in partnership with MITRE CTID, we are setting a new standard for data protection and insider threat mitigation," said John Stringer, Head of Product at Next DLP.
  • To learn more about Next's alignment with the MITRE Insider Threat Knowledge Base, we've put together an informative blog post available to read now.

NexCore Group and HCA Healthcare Break Ground on New Ambulatory Surgery Center in Orem, Utah

Retrieved on: 
화요일, 4월 30, 2024
MOB, HCA, ASC, Timpanogos Regional Hospital, HCA Healthcare, Operating, Physician, Growth, Hospital

DENVER, Colo., April 30, 2024 /PRNewswire-PRWeb/ -- NexCore Group, a leading healthcare real estate development, investment, and management company, has partnered with one of the nation's leading providers of healthcare service, HCA Healthcare, to celebrate the groundbreaking of a new ambulatory surgery center (ASC) in Orem, Utah. The ceremony took place on April 16, 2024.

Key Points: 
  • DENVER, Colo., April 30, 2024 /PRNewswire-PRWeb/ -- NexCore Group , a leading healthcare real estate development, investment, and management company, has partnered with one of the nation's leading providers of healthcare service, HCA Healthcare , to celebrate the groundbreaking of a new ambulatory surgery center (ASC) in Orem, Utah.
  • The new ASC will span 41,000 square feet and include 10 operating rooms, making it one of the largest surgery centers in HCA Healthcare's nationwide portfolio.
  • The ASC joint venture includes HCA's Surgery Ventures Group , and Central Utah Surgical Center (CUSC), an independent surgical group based in nearby Provo.
  • This new surgery center, a collaborative effort between NexCore Group, HCA Healthcare, and Central Utah Surgical Center, will cater to the community's present and future healthcare needs.

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments

Retrieved on: 
수요일, 4월 24, 2024
MMS, Patient, AI, HCA, Innovation, MD, HCA Healthcare, Workflow, Documentation, SVP, Physician, EDS, MBA, ED, SAN, Architecture

SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country.

Key Points: 
  • SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country.
  • As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits.
  • “Using Augmedix allowed me to spend more time with my patients and less time in front of my computer.
  • These AI models are utilized across different specialties and sections of the note to deliver high quality medical documentation.

HealthTrust Performance Group Celebrates 25 Years of Serving Healthcare

Retrieved on: 
월요일, 4월 29, 2024
Health, Consulting, Pharmaceutical, Surgery, Professional Services, Practice Management, Mental Health, Medical Devices, Managed Care, Hospitals, Health Technology, Nursing, Cardiology, Medical Supplies, Hospital, GPO, System, HCA Healthcare, Conference, Long-term care, Triad Hospitals, Community Health Systems, Caregiver, LifePoint Health

HealthTrust Performance Group , the leading provider-owned and operated national healthcare performance improvement company, is celebrating 25 years of accelerating savings and optimizing total performance for hospitals, health systems and providers across acute and non-acute sites of care.

Key Points: 
  • HealthTrust Performance Group , the leading provider-owned and operated national healthcare performance improvement company, is celebrating 25 years of accelerating savings and optimizing total performance for hospitals, health systems and providers across acute and non-acute sites of care.
  • “We are honored to celebrate 25 years of helping our members achieve their mission of delivering exceptional patient care,” said Ed Jones, President and Chief Executive Officer.
  • “Our operator expertise, aligned scale and innovation set HealthTrust apart in total performance optimization, spend management, and the development of a resilient global healthcare supply chain.”
    Since its inception, HealthTrust has supported nearly 500 health systems totaling more than 112,000 sites of care.
  • HealthTrust will celebrate 25 years of serving healthcare with members and suppliers during the 2024 HealthTrust University Conference, the company’s esteemed annual event that serves as a pivotal platform for bringing together prominent industry leaders, including HealthTrust executives, and distinguished experts from the healthcare and supply chain domains.

HCA Healthcare Reports First Quarter 2024 Results

Retrieved on: 
금요일, 4월 26, 2024
Other Health, Hospitals, Health, Practice Management, Health Technology, HCA, Public expenditure, Sale, Webcast, Adjustment, Central Time, HCA Healthcare

HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.

Key Points: 
  • HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024.
  • Net income attributable to HCA Healthcare, Inc. totaled $1.591 billion, or $5.93 per diluted share
    “The strong fundamentals we saw in our business this past year continued into the first quarter of 2024.
  • Revenues in the first quarter of 2024 totaled $17.339 billion, compared to $15.591 billion in the first quarter of 2023.
  • For the first quarter of 2024, Adjusted EBITDA totaled $3.353 billion, compared to $3.172 billion in the first quarter of 2023.

Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology

Retrieved on: 
화요일, 4월 23, 2024
Data Management, Other Health, Technology, Managed Care, General Health, Infectious Diseases, Hospitals, Clinical Trials, Other Technology, Biotechnology, Science, Software, Networks, Other Science, Research, Health, University, Hospital, Risk, CDC, University of California, HCA Healthcare, Patient safety, Fungal infection, Doctor of Science, Patient, MPH, UCI, NEJM, Harvard Medical School, Infection, Harvard Pilgrim Health Care, Doctor of Public Health, Senior advisor, COVID-19, CLUSTER, Vaccine

The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).

Key Points: 
  • The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).
  • While hospitals and health systems work to prevent infections and reduce the opportunity for outbreaks to occur, there is no standardized approach for detecting transmission.
  • Early detection can lead to a rapid response that reduces the chance for outbreaks to occur.
  • “The CLUSTER trial provides evidence that early detection powered by automation tools and quick action can prevent outbreaks from growing."